Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Systemic vasculitis during the course of systemic sclerosis: report of 12 cases and review of the literature.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE
- Publication Information:
Original Publication: Hagerstown, Md : Lippincott Williams & Wilkins
- Subject Terms:
- Abstract:
Although the presence of antineutrophil cytoplasmic antibodies (ANCA) has been reported in patients with systemic sclerosis (SSc), the association of SSc and systemic vasculitis has rarely been described. We obtained information on cases of systemic vasculitis associated with SSc in France from the French Vasculitis Study Group and all members of the French Research Group on Systemic Sclerosis. We identified 12 patients with systemic vasculitis associated with SSc: 9 with ANCA-associated systemic vasculitis (AASV) and 3 with mixed cryoglobulinemia vasculitis (MCV). In all AASV patients, SSc was of the limited type. The main complication of SSc was pulmonary fibrosis. Only 2 patients underwent a D-penicillamine regimen before the occurrence of AASV. The characteristics of AASV were microscopic polyangiitis (n = 7) and renal limited vasculitis (n = 2). Anti-myeloperoxidase antibodies were found in 8 of the 9 patients. The Five Factor Score was above 1 in 3 of the 9 patients. Of the 3 patients with MCV, Sjögren syndrome was confirmed in 2. We compared our findings with the results of a literature review (42 previously reported cases of AASV with SSc). Although rare, vasculitis is a complication of SSc. AASV is the most frequent type, and its diagnosis can be challenging when the kidney is injured. Better awareness of this rare association could facilitate earlier diagnosis and appropriate management to reduce damage.
- References:
Br J Rheumatol. 1990 Jun;29(3):234. (PMID: 2357511)
J Rheumatol. 1997 Jan;24(1):86-9. (PMID: 9002016)
Semin Arthritis Rheum. 2011 Oct;41(2):223-9. (PMID: 21277620)
Rheumatol Int. 1999;19(1-2):61-3. (PMID: 10651085)
Eur Respir J. 2010 Jul;36(1):116-21. (PMID: 19926741)
Am J Kidney Dis. 1997 Aug;30(2):279-81. (PMID: 9261042)
Arthritis Rheum. 1989 Sep;32(9):1128-34. (PMID: 2775321)
Br J Dermatol. 1996 Mar;134(3):407-10. (PMID: 8731661)
J Rheumatol. 1988 Feb;15(2):202-5. (PMID: 3361530)
Rheumatol Int. 2009 Jan;29(3):325-9. (PMID: 18719919)
Am J Kidney Dis. 2000 Sep;36(3):E16. (PMID: 10977809)
Am J Kidney Dis. 1991 Aug;18(2):175-9. (PMID: 1867175)
Acta Haematol. 1983;70(2):73-82. (PMID: 6408882)
J Rheumatol. 1996 Oct;23(10):1821-3. (PMID: 8895168)
J Eur Acad Dermatol Venereol. 2005 Sep;19(5):617-20. (PMID: 16164722)
Nephrol Dial Transplant. 1997 Mar;12(3):576-7. (PMID: 9075145)
Clin Rheumatol. 2005 Nov;24(6):658-60. (PMID: 15719151)
J Rheumatol. 2010 Jan;37(1):214-5. (PMID: 20040651)
Semin Arthritis Rheum. 2008 Feb;37(4):223-35. (PMID: 17692364)
Am J Kidney Dis. 2007 Nov;50(5):821-5. (PMID: 17954295)
Rheumatology (Oxford). 2007 Feb;46(2):321-6. (PMID: 16877466)
Clin Rheumatol. 1996 Sep;15(5):519-20. (PMID: 8894374)
Presse Med. 1999 Jan 16;28(2):67-70. (PMID: 9989295)
Medicine (Baltimore). 1996 Jan;75(1):17-28. (PMID: 8569467)
Clin Exp Immunol. 1990 Sep;81(3):380-3. (PMID: 2168822)
Medicine (Baltimore). 1974 Jan;53(1):1-46. (PMID: 4808710)
Clin Nephrol. 2008 Aug;70(2):183-5. (PMID: 18793540)
Clin Nephrol. 2007 Sep;68(3):165-70. (PMID: 17915619)
J Rheumatol. 2002 May;29(5):918-23. (PMID: 12022350)
Intern Med J. 2007 Mar;37(3):205-7. (PMID: 17316347)
Arthritis Rheum. 2001 Dec;45(6):533-6. (PMID: 11762687)
Clin Immunol Immunopathol. 1976 Jul;6(1):77-82. (PMID: 1084824)
J Rheumatol. 1987 Oct;14(5):942-8. (PMID: 3430523)
Arthritis Rheum. 2003 Jun 15;49(3):399-412. (PMID: 12794797)
Br J Rheumatol. 1994 Nov;33(11):1087-8. (PMID: 7981999)
J Rheumatol. 2002 Dec;29(12):2666-7. (PMID: 12465176)
Rheumatology (Oxford). 1999 Feb;38(2):190-1. (PMID: 10342639)
Clin Nephrol. 2000 Apr;53(4):296-300. (PMID: 10809419)
Ann Intern Med. 1997 Jun 1;126(11):866-73. (PMID: 9163287)
Eur Respir J. 2011 Jun;37(6):1503-13. (PMID: 21071471)
Rheumatol Int. 2006 Mar;26(5):465-8. (PMID: 16012875)
J Rheumatol. 2010 Mar;37(3):608-14. (PMID: 20110522)
Intern Med. 1997 Jul;36(7):508-13. (PMID: 9240503)
Ann Rheum Dis. 2008 Jan;67(1):110-6. (PMID: 17557890)
Ann Rheum Dis. 2007 Jul;66(7):940-4. (PMID: 17329309)
Presse Med. 1999 Apr 3;28(13):689-90. (PMID: 10228478)
J Rheumatol. 2006 Sep;33(9):1886-8. (PMID: 16832842)
Intern Med. 2004 Jun;43(6):496-502. (PMID: 15283187)
Clin Exp Rheumatol. 2002 May-Jun;20(3):411-4. (PMID: 12102482)
Rev Med Brux. 2008 Nov-Dec;29(6):559-67. (PMID: 19202712)
J Rheumatol. 1994 May;21(5):864-70. (PMID: 8064727)
Am J Kidney Dis. 1999 Apr;33(4):e3. (PMID: 10196034)
- Accession Number:
0 (Adrenal Cortex Hormones)
0 (Antibodies, Antineutrophil Cytoplasmic)
0 (Antirheumatic Agents)
0 (Biomarkers)
8N3DW7272P (Cyclophosphamide)
GNN1DV99GX (Penicillamine)
- Publication Date:
Date Created: 20121225 Date Completed: 20130312 Latest Revision: 20211021
- Publication Date:
20240829
- Accession Number:
PMC5370746
- Accession Number:
10.1097/MD.0b013e31827781fd
- Accession Number:
23263715
No Comments.